PhaseBio Pharmaceuticals

NasdaqGM:PHAS Stock Report

Mkt Cap: US$9.4m

PhaseBio Pharmaceuticals Company Information

PhaseBio Pharmaceuticals, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: PhaseBio Pharmaceuticals, Inc.
  • Ticker: PHAS
  • Exchange: NasdaqGM
  • Founded: 2002
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$9.398m
  • Shares outstanding: 49.86m
  • Website: https://phasebio.com

Number of Employees


Location

  • PhaseBio Pharmaceuticals, Inc.
  • 1 Great Valley Parkway
  • Suite 30
  • Malvern
  • Pennsylvania
  • 19355
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PHASNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDOct 2018
2K4DB (Deutsche Boerse AG)YesCommon StockDEEUROct 2018

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/10/04 00:00
End of Day Share Price2022/10/04 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.